Peter A.C. ’t Hoen

46.9k citations

207 papers · 7.9k indexed · 2 hit papers · h-index 47

Molecular Biology top 0.5%
Cancer Research top 1%
Genetics top 2%
Physiology top 5%
Cardiology and Cardiovascular Medicine top 2%

Co-authors: Johan T. den Dunnen Gert‐Jan B. van Ommen Henk P.J. Buermans Eleonora de Klerk Annemieke Aartsma‐Rus Yavuz Ariyürek Esther N. M. Nolte‐‘t Hoen Marca H. M. Wauben
Topics: Muscle Physiology and Disorders (44 papers)RNA Research and Splicing (35 papers)RNA modifications and cancer (30 papers)
Cited by: Molecular Biology Cancer Research Aging
Journals: Nucleic Acids Research Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Peter A.C. ’t Hoen

202 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms

2008 617 citations Peter A.C. ’t Hoen, Gert‐Jan B. van Ommen et al. profile →
Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions

2012 588 citations Peter A.C. ’t Hoen et al. profile →

Peers

Countries citing papers authored by Peter A.C. ’t Hoen

Since Specialization

Citations

This map shows the geographic impact of Peter A.C. ’t Hoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A.C. ’t Hoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A.C. ’t Hoen more than expected).

Fields of papers citing papers by Peter A.C. ’t Hoen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A.C. ’t Hoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A.C. ’t Hoen. The network helps show where Peter A.C. ’t Hoen may publish in the future.

Co-authorship network of co-authors of Peter A.C. ’t Hoen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A.C. ’t Hoen. A scholar is included among the top collaborators of Peter A.C. ’t Hoen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A.C. ’t Hoen. Peter A.C. ’t Hoen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The use of knowledge graphs for drug repurposing: From classical machine learning algorithms to graph neural networks 2025 ·Computers in Biology and Medicine ·Shuai Wei,(unknown),(unknown),Martijn A. Huynen,Peter A.C. ’t Hoen	1
2	The FAIR journey of a patient-driven registry: Reflections and practical solutions from the Duchenne Data Platform FAIRification experience 2025 ·Journal of Neuromuscular Diseases ·(unknown),Mark D. Wilkinson,(unknown),Adrian Tassoni,António Atalaia,(unknown),(unknown),(unknown),M Franken,Anneliene Hechtelt Jonker,Γεώργιος Παλιούρας,(unknown),Claudio Carta,(unknown),Marco Roos,Rajaram Kaliyaperumal,Teresinha Evangelista,Peter A.C. ’t Hoen,Elizabeth Vroom	0
3	Drug repurposing for rare: progress and opportunities for the rare disease community 2024 ·Frontiers in Medicine ·Anneliene Hechtelt Jonker,Daniel O’Connor,(unknown),(unknown),Μαρία Γώγου,Peter A.C. ’t Hoen,Martin de Kort,(unknown),(unknown),Anna M.G. Pasmooij	28
4	FAIR Data Cube, a FAIR data infrastructure for integrated multi-omics data analysis 2024 ·Journal of Biomedical Semantics ·(unknown),Thomas H. A. Ederveen,Anna Niehues,(unknown),(unknown),(unknown),(unknown),(unknown),Purva Kulkarni,K. Joeri van der Velde,Morris A. Swertz,(unknown),Alain J. van Gool,Peter A.C. ’t Hoen	2
5	Multi-omic profiling of pathogen-stimulated primary immune cells 2024 ·iScience ·(unknown),(unknown),Caspar I. van der Made,Simone Kersten,(unknown),(unknown),(unknown),Musa M. Mhlanga,Mihai G. Netea,Pieter‐Jan Volders,Alexander Hoischen,Peter A.C. ’t Hoen	0
6	PANDORA v2.0: Benchmarking peptide-MHC II models and software improvements 2023 ·Frontiers in Immunology ·(unknown),(unknown),(unknown),Peter A.C. ’t Hoen,Mohammad Hossein Karimi‐Jafari,Li C. Xue	3
7	Quantitative analysis of myofiber type composition in human and mouse skeletal muscles 2023 ·STAR Protocols ·Tooba Abbassi‐Daloii,(unknown),Hermien E. Kan,Erik B. van den Akker,Peter A.C. ’t Hoen,Vered Raz,Lenard M. Voortman	5
8	A Resource for Guiding Data Stewards to Make European Rare Disease Patient Registries FAIR 2023 ·Data Science Journal ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),K. Joeri van der Velde,(unknown),Claudio Carta,Ronald Cornet,Peter A.C. ’t Hoen,Annika Jacobsen,Morris A. Swertz,Marco Roos,(unknown)	2
9	A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients 2022 ·NAR Genomics and Bioinformatics ·(unknown),(unknown),(unknown),Eric T. Wang,Derick G. Wansink,Peter A.C. ’t Hoen	7
10	Entropy and Variability: A Second Opinion by Deep Learning 2022 ·Biomolecules ·(unknown),Li C. Xue,Peter A.C. ’t Hoen,Gert Vriend	3
11	Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries 2022 ·Orphanet Journal of Rare Diseases ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ronald Cornet,(unknown),Peter A.C. ’t Hoen,Franz Schaefer,K. Joeri van der Velde,Morris A. Swertz,Mark D. Wilkinson,Annika Jacobsen,Marco Roos	15
12	The de novo FAIRification process of a registry for vascular anomalies 2021 ·Orphanet Journal of Rare Diseases ·(unknown),Annika Jacobsen,Martijn G. Kersloot,(unknown),David van Enckevort,Rajaram Kaliyaperumal,Derk L. Arts,Peter A.C. ’t Hoen,Ronald Cornet,Marco Roos,Leo J. Schultze Kool	11
13	Mendelian randomization while jointly modeling cis genetics identifies causal relationships between gene expression and lipids 2020 ·Nature Communications ·Adriaan van der Graaf,Annique Claringbould,Antoine Rimbert,Bastiaan T. Heijmans,Peter A.C. ’t Hoen,Joyce B. J. van Meurs,Rick Jansen,Lude Franke,Harm-Jan Westra,Yang Li,Cisca Wijmenga,Serena Sanna	27
14	Search for Early Pancreatic Cancer Blood Biomarkers in Five European Prospective Population Biobanks Using Metabolomics 2019 ·Endocrinology ·Jesse Fest,Lisanne S. Vijfhuizen,Jelle J. Goeman,(unknown),Anni Joensuu,Markus Perola,Satu Männistö,Eivind Ness‐Jensen,Kristian Hveem,Toomas Haller,Neeme Tõnisson,Kairit Mikkel,Andres Metspalu,Cornelia M. van Duijn,M. Arfan Ikram,Bruno H. Stricker,Rikje Ruiter,Casper H.J. van Eijck,Gert‐Jan B. van Ommen,Peter A.C. ’t Hoen	20
15	Selective glucocorticoid receptor modulation prevents and reverses non-alcoholic fatty liver disease in male mice 2018 ·Endocrinology ·Lisa L. Koorneef,José K. van den Heuvel,Jan Kroon,Mariëtte R. Boon,Peter A.C. ’t Hoen,Kristina Hettne,(unknown),(unknown),Trea C.M. Streefland,Isabel M. Mol,Hetty C. M. Sips,Szymon M. Kiełbasa,Hailiang Mei,Joseph K. Belanoff,Alberto M. Pereira,Maaike H. Oosterveer,Hazel Hunt,Patrick C.N. Rensen,Onno C. Meijer	46
16	Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2 2016 ·Clinical Cancer Research ·Margot J. Pont,(unknown),Edith D. van der Meijden,Cornelis A.M. van Bergen,Michel G.D. Kester,(unknown),Martijn Vermaat,(unknown),Erik W.A. Marijt,Szymon M. Kiełbasa,Peter A.C. ’t Hoen,J.H. Frederik Falkenburg,Marieke Griffioen	13
17	Finding Novel Associations Across Domains Using Linked Data: a Case Study on Genetic Variants Disrupting Transcription Start Sites. 2015 ·Eelke van der Horst,Rajaram Kaliyaperumal,Zuotian Tatum,Mark Thompson,Erik Schultes,Eleni Mina,Ivo F.A.C. Fokkema,Johan T. den Dunnen,Marco Roos,Jeroen F. J. Laros,Barend Mons,Kristina Hettne,Peter A.C. ’t Hoen	1
18	Coexpression Network Analysis Identifies Transcriptional Modules Related to Proastrocytic Differentiation and Sprouty Signaling in Glioma 2010 ·Cancer Research ·Alexander E. Ivliev,Peter A.C. ’t Hoen,Marina G. Sergeeva	79
19	Prorenin Induces Intracellular Signaling in Cardiomyocytes Independently of Angiotensin II 2006 ·Hypertension ·Jasper J. Saris,Peter A.C. ’t Hoen,Ingrid M. Garrelds,Dick H. W. Dekkers,Johan T. den Dunnen,Jos M. J. Lamers,A.H. Jan Danser	196
20	Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein‐based assay 2002 ·European Journal of Biochemistry ·Peter A.C. ’t Hoen,(unknown),Jan N. M. Commandeur,Nico Vermeulen,Muthiah Manoharan,Theo J.C. van Berkel,E.A.L. Biessen,Martin K. Bijsterbosch	9

About Peter A.C. ’t Hoen

Peter A.C. ’t Hoen is a scholar working on Molecular Biology, Information Systems and Management and Cancer Research, having authored 207 papers that have together received 7.9k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (44 papers), RNA Research and Splicing (35 papers) and RNA modifications and cancer (30 papers). The work is most often cited by research in Molecular Biology (6.1k citations), Cancer Research (1.2k citations) and Aging (66 citations). Peter A.C. ’t Hoen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Johan T. den Dunnen, Gert‐Jan B. van Ommen, Henk P.J. Buermans, Eleonora de Klerk, Annemieke Aartsma‐Rus, Yavuz Ariyürek, Esther N. M. Nolte‐‘t Hoen, Marca H. M. Wauben, Willem Stoorvogel and Maaike Waasdorp. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact